Information  X 
Enter a valid email address

Xenetic Biosciences (XEN)

  Print      Mail a friend

Thursday 08 March, 2012

Xenetic Biosciences

Additional Listing

RNS Number : 9478Y
Xenetic Biosciences PLC
08 March 2012



Xenetic Biosciences plc


Additional listing


Xenetic Biosciences plc ("Xenetic" or "the Company") announces that application has been made to AIM, a market of the London Stock Exchange plc, for the admission of 61,046 ordinary shares of 0.5p each (the "New Ordinary Shares").


The New Ordinary Shares are being admitted pursuant to the exercise of options under the Company's Unapproved Share Option Plan.


It is expected that dealings in the New Ordinary Shares, which will rank pari passu in all respects with the existing issued share capital of the Company, will commence on 9 March 2012.


Following admission the Company will have 407,875,428 ordinary shares in issue.




Xenetic Biosciences plc

+44 (0)20 7389 5015

M. Scott Maguire, Chief Executive Officer

Singer Capital Markets (NOMAD & Broker)

+44 (0)20 3205 7500

Claes Spång

Walbrook PR

+44 (0)20 7933 8780

Paul McManus

Paul Cornelius


This information is provided by RNS
The company news service from the London Stock Exchange